| AI Screening for BDD in Aesthetic Surgery: Enhancing Safety and Outcomes (NCT06584305) | Bukret Plastic Surgery | 2021-01-02 |
| Perceptual Abnormalities and Their Malleability in BDD (NCT04373629) | Centre for Addiction and Mental Health | 2020-12-01 |
| Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD) (NCT03673046) | Massachusetts General Hospital | 2019-09-17 |
| Brain Correlates of Self-Focused Processing (NCT02808702) | Massachusetts General Hospital | 2017-05-01 |
| Milk Thistle in Body Dysmorphic Disorder (NCT02843451) | University of Chicago | 2016-10-01 |
| Interpretation Bias Modification for Body Dysmorphic Disorder (NCT02635152) | Florida State University | 2015-09-01 |
| Oxytocin Administration in BDD and OCD (NCT02671266) | Massachusetts General Hospital | 2014-12-01 |
| Internet Delivered CBT for Body Dysmorphic Disorder (NCT02010619) | Karolinska Institutet | 2013-11-01 |
| Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder (NCT01453439) | Massachusetts General Hospital | 2011-08-01 |
| Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals (NCT01075672) | Massachusetts General Hospital | 2010-01-01 |
| An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder (NCT01038128) | Mclean Hospital | 2009-12-01 |
| Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder (NCT01002326) | Massachusetts General Hospital | 2009-06-01 |
| Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD) (NCT00871143) | Institute of Psychiatry, London | 2009-04-01 |
| Escitalopram Neuroimaging Supplement (NCT01398865) | Massachusetts General Hospital | 2008-12-01 |
| D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder (NCT00842309) | Massachusetts General Hospital | 2008-11-01 |
| CBT as an Adjunct to SRIs in the Treatment of BDD (NCT00211809) | Icahn School of Medicine at Mount Sinai | 2008-09-01 |
| Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder (NCT00265109) | Butler Hospital | 2004-12-01 |
| Fluoxetine in Pediatric Body Dysmorphic Disorder (NCT00245635) | Montefiore Medical Center | 2004-11-01 |
| Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder (NCT00106223) | Massachusetts General Hospital | 2004-04-01 |